125 related articles for article (PubMed ID: 12797450)
1. Interplay between human papillomaviruses and dendritic cells.
Offringa R; de Jong A; Toes RE; van der Burg SH; Melief CJ
Curr Top Microbiol Immunol; 2003; 276():215-40. PubMed ID: 12797450
[TBL] [Abstract][Full Text] [Related]
2. DNA vaccines for cervical cancer: from bench to bedside.
Hung CF; Monie A; Alvarez RD; Wu TC
Exp Mol Med; 2007 Dec; 39(6):679-89. PubMed ID: 18160838
[TBL] [Abstract][Full Text] [Related]
3. Host responses to infection with human papillomavirus.
Stanley MA; Sterling JC
Curr Probl Dermatol; 2014; 45():58-74. PubMed ID: 24643178
[TBL] [Abstract][Full Text] [Related]
4. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.
Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617
[TBL] [Abstract][Full Text] [Related]
5. Immune evasion in human papillomavirus-associated cervical cancer.
Tindle RW
Nat Rev Cancer; 2002 Jan; 2(1):59-65. PubMed ID: 11902586
[TBL] [Abstract][Full Text] [Related]
6. HPV modulation of host immune responses.
Feller L; Wood NH; Khammissa RA; Chikte UM; Meyerov R; Lemmer J
SADJ; 2010 Jul; 65(6):266-8. PubMed ID: 20879650
[TBL] [Abstract][Full Text] [Related]
7. Microwave therapy for cutaneous human papilloma virus infection.
Bristow I; Lim WC; Lee A; Holbrook D; Savelyeva N; Thomson P; Webb C; Polak M; Ardern-Jones MR
Eur J Dermatol; 2017 Oct; 27(5):511-518. PubMed ID: 29084638
[TBL] [Abstract][Full Text] [Related]
8. Immune responses to human papillomavirus.
Stanley M
Vaccine; 2006 Mar; 24 Suppl 1():S16-22. PubMed ID: 16219398
[TBL] [Abstract][Full Text] [Related]
9. The role of the immune system in anogenital human papillomavirus.
Frazer IH
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
[TBL] [Abstract][Full Text] [Related]
10. Immunology of anogenital human papillomavirus (HPV) infection.
Tindle RW; Frazer IH
Aust N Z J Obstet Gynaecol; 1990 Nov; 30(4):370-5. PubMed ID: 1964551
[TBL] [Abstract][Full Text] [Related]
11. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
Berti FCB; Pereira APL; Cebinelli GCM; Trugilo KP; Brajão de Oliveira K
Cytokine Growth Factor Rev; 2017 Apr; 34():1-13. PubMed ID: 28365229
[TBL] [Abstract][Full Text] [Related]
12. Vaccines and immunization against human papillomavirus.
Christensen ND; Budgeon LR
Curr Probl Dermatol; 2014; 45():252-64. PubMed ID: 24643192
[TBL] [Abstract][Full Text] [Related]
13. Role of innate immunity against human papillomavirus (HPV) infections and effect of adjuvants in promoting specific immune response.
Amador-Molina A; Hernández-Valencia JF; Lamoyi E; Contreras-Paredes A; Lizano M
Viruses; 2013 Oct; 5(11):2624-42. PubMed ID: 24169630
[TBL] [Abstract][Full Text] [Related]
14. An improved rearranged Human Papillomavirus Type 16 E7 DNA vaccine candidate (HPV-16 E7SH) induces an E7 wildtype-specific T cell response.
Ohlschläger P; Pes M; Osen W; Dürst M; Schneider A; Gissmann L; Kaufmann AM
Vaccine; 2006 Apr; 24(15):2880-93. PubMed ID: 16472545
[TBL] [Abstract][Full Text] [Related]
15. The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
Yang A; Farmer E; Lin J; Wu TC; Hung CF
Virus Res; 2017 Mar; 231():148-165. PubMed ID: 27932207
[TBL] [Abstract][Full Text] [Related]
16. Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers.
Ling M; Kanayama M; Roden R; Wu TC
J Biomed Sci; 2000; 7(5):341-56. PubMed ID: 10971133
[TBL] [Abstract][Full Text] [Related]
17. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
[TBL] [Abstract][Full Text] [Related]
18. Immunological role of dendritic cells in cervical cancer.
Manickam A; Sivanandham M; Tourkova IL
Adv Exp Med Biol; 2007; 601():155-62. PubMed ID: 17713002
[TBL] [Abstract][Full Text] [Related]
19. Innate immune response against HPV: Possible crosstalking with endocervical γδ T cells.
Dogan S; Terzioglu E; Ucar S
J Reprod Immunol; 2021 Nov; 148():103435. PubMed ID: 34741834
[TBL] [Abstract][Full Text] [Related]
20. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
